| Dr Fernando Antonio Moya-huff, MD | |
|
1228 S Pine Island Rd Ste 310, Plantation, FL 33324-4583 | |
| (954) 392-1725 | |
| (954) 837-1113 |
| Full Name | Dr Fernando Antonio Moya-huff |
|---|---|
| Gender | Male |
| Speciality | Orthopedic Surgery |
| Experience | 31 Years |
| Location | 1228 S Pine Island Rd Ste 310, Plantation, Florida |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1154391407 | NPI | - | NPPES |
| 002876700 | Other | FL | GROUP MEDICAID |
| 002610900 | Medicaid | FL |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207X00000X | Orthopaedic Surgery | ME75432 (Florida) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Doctors Hospital | Coral gables, FL | Hospital |
| Memorial Hospital Miramar | Miramar, FL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Baptist Health Medical Group Orthopedics, Llc | 9335228899 | 59 |
News Archive
The Bill & Melinda Gates Foundation recently awarded a $4.8 million grant to the London School of Hygiene and Tropical Medicine to study and improve sanitation systems in the developing world, the Seattle Times' blog, "The Business of Giving" reports.
EpiCept Corporation today announced that it has received notification from the Nasdaq Listing Qualifications Department that it has regained compliance with the continued listing requirement of the Nasdaq Capital Market that it maintain a minimum market value of its listed securities of at least $35 million pursuant to Listing Rule 5550(b)(2).
Rexahn Pharmaceuticals, Inc. (NYSE Amex: RNN), a clinical stage pharmaceutical company commercializing potential best in class oncology and central nervous system (CNS) therapeutics, today announced that it has closed on its previously announced licensing and stock purchase agreements with Teva Pharmaceutical Industries Limited, a top 20 pharmaceutical company, for the development of its novel anti-cancer compound, RX-3117. RX-3117 is a small molecule, new chemical entity (NCE), nucleoside compound that has an anti-metabolite mechanism of action, and has therapeutic potential in a broad range of cancers including colon, lung and pancreatic cancer.
The Zika virus (ZIKV) outbreak in Brazil in 2015 sparked for many health agencies and scientists to study the pathogen, which has been linked to microcephaly and other fetal neurological disorders collectively known as Congenital Zika Syndrome.
› Verified 3 days ago
| Entity Name | Baptist Health Medical Group Orthopedics, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1700072535 PECOS PAC ID: 9335228899 Enrollment ID: O20080508000540 |
News Archive
The Bill & Melinda Gates Foundation recently awarded a $4.8 million grant to the London School of Hygiene and Tropical Medicine to study and improve sanitation systems in the developing world, the Seattle Times' blog, "The Business of Giving" reports.
EpiCept Corporation today announced that it has received notification from the Nasdaq Listing Qualifications Department that it has regained compliance with the continued listing requirement of the Nasdaq Capital Market that it maintain a minimum market value of its listed securities of at least $35 million pursuant to Listing Rule 5550(b)(2).
Rexahn Pharmaceuticals, Inc. (NYSE Amex: RNN), a clinical stage pharmaceutical company commercializing potential best in class oncology and central nervous system (CNS) therapeutics, today announced that it has closed on its previously announced licensing and stock purchase agreements with Teva Pharmaceutical Industries Limited, a top 20 pharmaceutical company, for the development of its novel anti-cancer compound, RX-3117. RX-3117 is a small molecule, new chemical entity (NCE), nucleoside compound that has an anti-metabolite mechanism of action, and has therapeutic potential in a broad range of cancers including colon, lung and pancreatic cancer.
The Zika virus (ZIKV) outbreak in Brazil in 2015 sparked for many health agencies and scientists to study the pathogen, which has been linked to microcephaly and other fetal neurological disorders collectively known as Congenital Zika Syndrome.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Fernando Antonio Moya-huff, MD Po Box 100905, Atlanta, GA 30384-0905 Ph: () - | Dr Fernando Antonio Moya-huff, MD 1228 S Pine Island Rd Ste 310, Plantation, FL 33324-4583 Ph: (954) 392-1725 |
News Archive
The Bill & Melinda Gates Foundation recently awarded a $4.8 million grant to the London School of Hygiene and Tropical Medicine to study and improve sanitation systems in the developing world, the Seattle Times' blog, "The Business of Giving" reports.
EpiCept Corporation today announced that it has received notification from the Nasdaq Listing Qualifications Department that it has regained compliance with the continued listing requirement of the Nasdaq Capital Market that it maintain a minimum market value of its listed securities of at least $35 million pursuant to Listing Rule 5550(b)(2).
Rexahn Pharmaceuticals, Inc. (NYSE Amex: RNN), a clinical stage pharmaceutical company commercializing potential best in class oncology and central nervous system (CNS) therapeutics, today announced that it has closed on its previously announced licensing and stock purchase agreements with Teva Pharmaceutical Industries Limited, a top 20 pharmaceutical company, for the development of its novel anti-cancer compound, RX-3117. RX-3117 is a small molecule, new chemical entity (NCE), nucleoside compound that has an anti-metabolite mechanism of action, and has therapeutic potential in a broad range of cancers including colon, lung and pancreatic cancer.
The Zika virus (ZIKV) outbreak in Brazil in 2015 sparked for many health agencies and scientists to study the pathogen, which has been linked to microcephaly and other fetal neurological disorders collectively known as Congenital Zika Syndrome.
› Verified 3 days ago
Dr. Martin E Hale, M.D. Orthopedic Surgery Medicare: Medicare Enrolled Practice Location: 499 Nw 70th Ave, Suite 200, Plantation, FL 33317 Phone: 954-474-3223 Fax: 954-474-3226 | |
Dr. Robert Wells Baylis, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 350 N Pine Island Rd, Suite 200, Plantation, FL 33324 Phone: 954-476-8800 Fax: 954-476-1362 | |
Dr. David A Blum, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 600 S Pine Island Rd, Suite 300, Plantation, FL 33324 Phone: 954-473-6344 Fax: 954-476-9077 | |
Dr. Jahangir Asghar, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 499 Nw 70th Ave Ste 200, Plantation, FL 33317 Phone: 954-223-5843 Fax: 954-223-5484 | |
Alexandr Aylyarov, M.D. Orthopedic Surgery Medicare: Medicare Enrolled Practice Location: 8251 W Broward Blvd Ste 300, Plantation, FL 33324 Phone: 954-724-3400 | |
Mr. Andrew S Ellowitz, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 4101 Nw 4th St, Suite 305, Plantation, FL 33317 Phone: 954-583-8130 Fax: 954-583-8956 |